CALGARY, Alberta--(BUSINESS WIRE)--July 21, 2005--Resverlogix Corp. (TSX:RVX), is pleased to announce that it has developed and launched a technical animation on its lead technology NEXVAS(TM). The animation will provide interested parties with an overview of how NEXVAS(TM) works. The animation describes the cardiovascular marketplace, underlying causes of atherosclerosis and the emerging role that ApoA1 enhancement technologies such as NEXVAS(TM) are expected to play in the future role of Cardiovascular Disease (CVD) management.
